Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies

被引:133
作者
Mamoulakis, Charalampos [1 ]
Tsarouhas, Konstantinos [2 ]
Fragkiadoulaki, Irini [3 ]
Heretis, Ioannis [1 ]
Wilks, Martin F. [4 ]
Spandidos, Demetrios A. [5 ]
Tsitsimpikou, Christina [6 ]
Tsatsakis, Aristides [3 ]
机构
[1] Univ Crete, Univ Gen Hosp Heraklion, Med Sch, Dept Urol, Iraklion, Crete, Greece
[2] Univ Gen Hosp Larisa, Dept Cardiol, Larisa, Greece
[3] Univ Crete, Dept Forens Sci & Toxicol, Fac Med, Iraklion 71003, Greece
[4] Univ Basel, Swiss Ctr Appl Human Toxicol, CH-4055 Basel, Switzerland
[5] Univ Crete, Med Sch, Dept Virol, Iraklion, Crete, Greece
[6] Gen Chem State Lab Greece, Dept Hazardous Subst Mixtures & Articles, Athens, Greece
关键词
Contrast media; Kidney; Nephropathy; Prevention; Toxicity; ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; IODINATED CONTRAST; N-ACETYLCYSTEINE; CORONARY-ANGIOGRAPHY; SODIUM-BICARBONATE; OXIDATIVE STRESS; RISK-FACTORS; ASCORBIC-ACID;
D O I
10.1016/j.pharmthera.2017.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Contrast-induced nephropathy (CIN) is reversible acute renal failure observed following administration of iodinated contrast media (CM) during angiographic or other medical procedures such as urography. There are various mechanisms through which CM develop their nephrotoxic effects, including oxidative stress and apoptosis. CIN is a real-life, albeit not very rare, entity. Exact pathophysiology remains obscure and no standard diagnostic criteria apply. The Acute Kidney Injury Network criteria was recently employed but its incidence/clinical significance warrants further clarification based on recent methodological advancements, because most published studies to date were contaminated by bias. The current study is a comprehensive review conducted to provide an overview of the basic concepts of CIN and summarize recent knowledge on its pathophysiology and the evidence supporting potential prevention strategies. CIN is expected to increase morbidity, hospital stay and mortality, while all patients scheduled to receive CM should undergo risk assessment for CIN and high-risk patients may be considered candidates for prevention strategies. The value of using compounds with antioxidant properties other than sodium bicarbonate, remains controversial, warranting further clinical investigation. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 112
页数:14
相关论文
共 50 条
  • [31] Risk factors and therapy strategies for contrast-induced nephropathy
    Toprak, Omer
    Cirit, Mustafa
    RENAL FAILURE, 2006, 28 (05) : 365 - 381
  • [32] Contrast-induced nephropathy
    Walsh, Stewart R.
    Tang, Tjun
    Gaunt, Michael E.
    Boyle, Jonathan R.
    JOURNAL OF ENDOVASCULAR THERAPY, 2007, 14 (01) : 92 - 100
  • [33] Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies
    Azzalini, Lorenzo
    Spagnoli, Vincent
    Ly, Hung Q.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (02) : 247 - 255
  • [34] Contrast-induced Nephropathy Essentials and Concerns
    Samadian, Fariba
    Dalili, Nooshin
    Mahmoudieh, Leila
    Ziaei, Shadi
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (03) : 135 - 141
  • [35] Advances in the pathogenesis and prevention of contrast-induced nephropathy
    Zhang, Fangfei
    Lu, Zeyuan
    Wang, Feng
    LIFE SCIENCES, 2020, 259
  • [36] Risk factors for contrast-induced nephropathy
    Toprak, Omer
    Girit, Mustafa
    KIDNEY & BLOOD PRESSURE RESEARCH, 2006, 29 (02) : 84 - 93
  • [37] Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial
    Kong, De-Gui
    Hou, Yan-Fang
    Ma, Long-Le
    Yao, Dao-Kuo
    Wang, Le-Xin
    ACTA CARDIOLOGICA, 2012, 67 (05) : 565 - 569
  • [38] Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy: The Efficacy of High Concentration Solution
    Tamai, Nozomu
    Ito, Shigenori
    Nakasuka, Kosuke
    Morimoto, Kotaro
    Miyata, Kazuyuki
    Inomata, Masahiko
    Yoshida, Takayuki
    Suzuki, Shin
    Murakami, Yoshimasa
    Sato, Koichi
    JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (09) : 439 - 442
  • [39] Prevention and Treatment of Contrast-Induced Nephropathy
    Al-Ghonaim, Mohammed
    Pannu, Neesh
    TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 9 (02) : 42 - 49
  • [40] Statins in the Prevention of Contrast-Induced Nephropathy
    Chyou A.C.
    Thodge A.
    Feldman D.N.
    Swaminathan R.V.
    Current Treatment Options in Cardiovascular Medicine, 2015, 17 (4)